Fidson Healthcare PLC, a pharmaceutical company in Nigeria, reported revenue of N84.2 billion for 2024, up 59% from N53.1 billion in 2023, due to increased demand for medication.
The company made this announcement during its 30th anniversary, consolidating its position as the largest pharmaceutical player in the country.
According to the company’s recently released 2024 audited financial statements, net profit soared by 60% to N5.78 billion, while profit before tax climbed to N7.7 billion, representing a 30% increase. The market responded positively, with Fidson’s market capitalization reaching N44.64 billion as of April 2025.